Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Greenberg

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Pediatrics|July 5, 2005
Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipientsPhilana Ling Lin, Marian G Michaels, Michael Green, et al.
Vaccine|February 7, 2021
Introductory paper: High-dose influenza vaccineMia Diaco, Lee-Jah Chang, Bruce Seet, et al.
Annals of Family Medicine|December 7, 2006
Improving influenza vaccination rates of high-risk inner-city children over 2 intervention yearsRichard K Zimmerman, Alejandro Hoberman, Mary Patricia Nowalk, et al.
Vaccine|February 13, 2019
Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable methodYinong Young-Xu, Julia Thornton Snider, Robertus van Aalst, et al.
The Pediatric Infectious Disease Journal|June 27, 2013
Immune responses in infants whose mothers received Tdap vaccine during pregnancyAbbey J Hardy-Fairbanks, Stephanie J Pan, Michael D Decker, et al.
Pediatrics|April 3, 2002
Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancyDavid P Greenberg, Larry K Pickering, Shelly D Senders, et al.
Vaccine|September 24, 2013
Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of ageGeoffrey J Gorse, Ann R Falsey, Carol M Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adultsJames D Cherry, Swei-Ju Chang, David Klein, et al.
The New England Journal of Medicine|October 14, 2005
Efficacy of an acellular pertussis vaccine among adolescents and adultsJoel I Ward, James D Cherry, Swei-Ju Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)Joel I Ward, James D Cherry, Swei-Ju Chang, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Pediatrics|July 5, 2005
Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipientsPhilana Ling Lin, Marian G Michaels, Michael Green, et al.
Vaccine|February 7, 2021
Introductory paper: High-dose influenza vaccineMia Diaco, Lee-Jah Chang, Bruce Seet, et al.
Annals of Family Medicine|December 7, 2006
Improving influenza vaccination rates of high-risk inner-city children over 2 intervention yearsRichard K Zimmerman, Alejandro Hoberman, Mary Patricia Nowalk, et al.
Vaccine|February 13, 2019
Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable methodYinong Young-Xu, Julia Thornton Snider, Robertus van Aalst, et al.
The Pediatric Infectious Disease Journal|June 27, 2013
Immune responses in infants whose mothers received Tdap vaccine during pregnancyAbbey J Hardy-Fairbanks, Stephanie J Pan, Michael D Decker, et al.
Pediatrics|April 3, 2002
Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancyDavid P Greenberg, Larry K Pickering, Shelly D Senders, et al.
Vaccine|September 24, 2013
Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of ageGeoffrey J Gorse, Ann R Falsey, Carol M Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adultsJames D Cherry, Swei-Ju Chang, David Klein, et al.
The New England Journal of Medicine|October 14, 2005
Efficacy of an acellular pertussis vaccine among adolescents and adultsJoel I Ward, James D Cherry, Swei-Ju Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)Joel I Ward, James D Cherry, Swei-Ju Chang, et al.
Pageof 7